Cargando…

Proline Metabolism in Malignant Gliomas: A Systematic Literature Review

SIMPLE SUMMARY: Studies of various types of cancers have found proline metabolism to be a key player in tumor development, involved in basic metabolic pathways, regulating cell proliferation, survival, and signaling. Here, we systematically searched the literature to find data on proline metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawicka, Magdalena M., Sawicki, Karol, Łysoń, Tomasz, Polityńska, Barbara, Miltyk, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027994/
https://www.ncbi.nlm.nih.gov/pubmed/35454935
http://dx.doi.org/10.3390/cancers14082030
_version_ 1784691506730237952
author Sawicka, Magdalena M.
Sawicki, Karol
Łysoń, Tomasz
Polityńska, Barbara
Miltyk, Wojciech
author_facet Sawicka, Magdalena M.
Sawicki, Karol
Łysoń, Tomasz
Polityńska, Barbara
Miltyk, Wojciech
author_sort Sawicka, Magdalena M.
collection PubMed
description SIMPLE SUMMARY: Studies of various types of cancers have found proline metabolism to be a key player in tumor development, involved in basic metabolic pathways, regulating cell proliferation, survival, and signaling. Here, we systematically searched the literature to find data on proline metabolism in malignant glial tumors. Despite limited availability, existing studies have found several ways in which proline metabolism may affect the development of gliomas, involving the maintenance of redox balance, providing essential glutamate, and affecting major signaling pathways. Metabolomic profiling has revealed the importance of proline as a link to basic cell metabolic cycles and shown it to be correlated with overall survival. Emerging knowledge on the role of proline in general oncology encourages further studies on malignant gliomas. ABSTRACT: Background: Proline has attracted growing interest because of its diverse influence on tumor metabolism and the discovery of the regulatory mechanisms that appear to be involved. In contrast to general oncology, data on proline metabolism in central nervous system malignancies are limited. Materials and Methods: We performed a systematic literature review of the MEDLINE and EMBASE databases according to PRISMA guidelines, searching for articles concerning proline metabolism in malignant glial tumors. From 815 search results, we identified 14 studies pertaining to this topic. Results: The role of the proline cycle in maintaining redox balance in IDH-mutated gliomas has been convincingly demonstrated. Proline is involved in restoring levels of glutamate, the main glial excitatory neurotransmitter. Proline oxidase influences two major signaling pathways: p53 and NF- κB. In metabolomics studies, the metabolism of proline and its link to the urea cycle was found to be a prognostic factor for survival and a marker of malignancy. Data on the prolidase concentration in the serum of glioblastoma patients are contradictory. Conclusions: Despite a paucity of studies in the literature, the available data are interesting enough to encourage further research, especially in terms of extrapolating what we have learned of proline functions from other neoplasms to malignant gliomas.
format Online
Article
Text
id pubmed-9027994
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90279942022-04-23 Proline Metabolism in Malignant Gliomas: A Systematic Literature Review Sawicka, Magdalena M. Sawicki, Karol Łysoń, Tomasz Polityńska, Barbara Miltyk, Wojciech Cancers (Basel) Systematic Review SIMPLE SUMMARY: Studies of various types of cancers have found proline metabolism to be a key player in tumor development, involved in basic metabolic pathways, regulating cell proliferation, survival, and signaling. Here, we systematically searched the literature to find data on proline metabolism in malignant glial tumors. Despite limited availability, existing studies have found several ways in which proline metabolism may affect the development of gliomas, involving the maintenance of redox balance, providing essential glutamate, and affecting major signaling pathways. Metabolomic profiling has revealed the importance of proline as a link to basic cell metabolic cycles and shown it to be correlated with overall survival. Emerging knowledge on the role of proline in general oncology encourages further studies on malignant gliomas. ABSTRACT: Background: Proline has attracted growing interest because of its diverse influence on tumor metabolism and the discovery of the regulatory mechanisms that appear to be involved. In contrast to general oncology, data on proline metabolism in central nervous system malignancies are limited. Materials and Methods: We performed a systematic literature review of the MEDLINE and EMBASE databases according to PRISMA guidelines, searching for articles concerning proline metabolism in malignant glial tumors. From 815 search results, we identified 14 studies pertaining to this topic. Results: The role of the proline cycle in maintaining redox balance in IDH-mutated gliomas has been convincingly demonstrated. Proline is involved in restoring levels of glutamate, the main glial excitatory neurotransmitter. Proline oxidase influences two major signaling pathways: p53 and NF- κB. In metabolomics studies, the metabolism of proline and its link to the urea cycle was found to be a prognostic factor for survival and a marker of malignancy. Data on the prolidase concentration in the serum of glioblastoma patients are contradictory. Conclusions: Despite a paucity of studies in the literature, the available data are interesting enough to encourage further research, especially in terms of extrapolating what we have learned of proline functions from other neoplasms to malignant gliomas. MDPI 2022-04-17 /pmc/articles/PMC9027994/ /pubmed/35454935 http://dx.doi.org/10.3390/cancers14082030 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Sawicka, Magdalena M.
Sawicki, Karol
Łysoń, Tomasz
Polityńska, Barbara
Miltyk, Wojciech
Proline Metabolism in Malignant Gliomas: A Systematic Literature Review
title Proline Metabolism in Malignant Gliomas: A Systematic Literature Review
title_full Proline Metabolism in Malignant Gliomas: A Systematic Literature Review
title_fullStr Proline Metabolism in Malignant Gliomas: A Systematic Literature Review
title_full_unstemmed Proline Metabolism in Malignant Gliomas: A Systematic Literature Review
title_short Proline Metabolism in Malignant Gliomas: A Systematic Literature Review
title_sort proline metabolism in malignant gliomas: a systematic literature review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027994/
https://www.ncbi.nlm.nih.gov/pubmed/35454935
http://dx.doi.org/10.3390/cancers14082030
work_keys_str_mv AT sawickamagdalenam prolinemetabolisminmalignantgliomasasystematicliteraturereview
AT sawickikarol prolinemetabolisminmalignantgliomasasystematicliteraturereview
AT łysontomasz prolinemetabolisminmalignantgliomasasystematicliteraturereview
AT politynskabarbara prolinemetabolisminmalignantgliomasasystematicliteraturereview
AT miltykwojciech prolinemetabolisminmalignantgliomasasystematicliteraturereview